Antiretroviral therapy coverage for PMTCT in Djibouti
Djibouti: Antiretroviral therapy coverage for PMTCT was 38.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage for PMTCT in Djibouti, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.
Analysis
Djibouti recorded 38.0% for antiretroviral therapy coverage for pmtct in 2024.
That represents a change of up 26.7% on the previous year and up 26.7% over ten years.
Over the whole period, antiretroviral therapy coverage for pmtct in Djibouti peaked at 49.0% in 2016 and was at its lowest, 0.0%, in 2000.
Djibouti ranks 74th of 84 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage for PMTCT in Djibouti, year by year
| Year | % of pregnant women living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 3.0% | — |
| 2004 | 4.0% | +33.3% |
| 2005 | 6.0% | +50.0% |
| 2006 | 13.0% | +116.7% |
| 2007 | 15.0% | +15.4% |
| 2008 | 13.0% | -13.3% |
| 2009 | 10.0% | -23.1% |
| 2010 | 13.0% | +30.0% |
| 2011 | 17.0% | +30.8% |
| 2012 | 17.0% | +0.0% |
| 2013 | 14.0% | -17.6% |
| 2014 | 30.0% | +114.3% |
| 2015 | 41.0% | +36.7% |
| 2016 | 49.0% | +19.5% |
| 2017 | 33.0% | -32.7% |
| 2018 | 36.0% | +9.1% |
| 2019 | 32.0% | -11.1% |
| 2020 | 41.0% | +28.1% |
| 2021 | 41.0% | +0.0% |
| 2022 | 20.0% | -51.2% |
| 2023 | 30.0% | +50.0% |
| 2024 | 38.0% | +26.7% |
Djibouti compared with similar countries
- Djibouti's 38.0% is below the median for lower middle income countries, which is 83.5%, 46% of the median. (32 countries reporting)
- Djibouti's 38.0% is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 32.0%, 1.2× the median. (9 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 6.4% | 0.0% | 15.0% | 10 |
| 2010s | 28.2% | 13.0% | 49.0% | 10 |
| 2020s | 34.0% | 20.0% | 41.0% | 5 |
Countries ranked near Djibouti
- 73 Mauritania 39.0% compare
- 75 Democratic Republic of Congo 32.0% compare
- 75 Tunisia 32.0% compare
- 77 Madagascar 30.0% compare
More health data for Djibouti
- Un projection of annual infant deaths, annual growth rate -1.5 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.2173 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,107 deaths per 1,000 people (2090)
- Number of infants who die before age 1 197 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.5299 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0481 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.5304 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage for pmtct in Djibouti?
- Antiretroviral therapy coverage for pmtct in Djibouti was 38.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage for pmtct recorded in Djibouti?
- The highest recorded value was 49.0% in 2016.
- What is the lowest antiretroviral therapy coverage for pmtct recorded in Djibouti?
- The lowest recorded value was 0.0% in 2000.
- How does Djibouti rank for antiretroviral therapy coverage for pmtct?
- Djibouti ranks 74th out of 84 countries with data for 2024.
- Is antiretroviral therapy coverage for pmtct rising or falling in Djibouti?
- Over the last ten years it is up 26.7%. The long-run trend across the full record is volatile.
- Where does this Djibouti data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).